PRECLINICAL PROFILE OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857

被引:23
|
作者
Taylor, J. G. [1 ]
Appleby, T. [1 ]
Barauskas, O. [1 ]
Chen, X. [1 ]
Dvory-Sobol, H. [1 ]
Gong, R. [1 ]
Lee, J. [1 ]
Nejati, E. [1 ]
Schultz, B. [1 ]
Wang, Y. [1 ]
Yang, C. [1 ]
Yu, M. [1 ]
Zipfel, S. [1 ]
Chan, K. [1 ]
机构
[1] Gilead Sci Inc, Foster City, CA 94404 USA
关键词
D O I
10.1016/S0168-8278(15)31102-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0899
引用
收藏
页码:S681 / S681
页数:1
相关论文
共 50 条
  • [1] EVALUATION OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857 IN HEALTHY VOLUNTEERS
    Kirby, B.
    Yang, J.
    Yang, C.
    Song, Q.
    Wang, Y.
    Taylor, J.
    Stamm, L.
    Mathias, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S663 - S663
  • [2] THE EFFECT OF RENAL OR HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF GS-9857, A PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR
    Lawitz, E.
    Marbury, T.
    Kirby, B. J.
    Au, N. T.
    Mathias, A.
    Stamm, L. M.
    Wei, H.
    Sajwani, K.
    Klein, G.
    Gane, Ed
    Robson, R.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S613 - S613
  • [3] Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®
    Taylor, James G.
    Zipfel, Sheila
    Ramey, Kyla
    Vivian, Randy
    Schrier, Adam
    Karki, Kapil K.
    Katana, Ashley
    Kato, Darryl
    Kobayashi, Tetsuya
    Martinez, Ruben
    Sangi, Michael
    Siegel, Dustin
    Tran, Chinh, V
    Yang, Zheng-Yu
    Zablocki, Jeff
    Yang, Cheng Y.
    Wang, Yujin
    Wang, Kelly
    Chan, Katie
    Barauskas, Ona
    Cheng, Guofeng
    Jin, Debi
    Schultze, Brian E.
    Appleby, Todd
    Villasenor, Armando G.
    Link, John O.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2428 - 2436
  • [4] THE PAN-GENOTYPIC NS3/4A PROTEASE INHIBITOR GS-9857 DEMONSTRATES POTENT ANTIVIRAL ACTIVITY IN PATIENTS INFECTED WITH HCV GENOTYPE 1, 2, 3 OR 4 IN A 3-DAY MONOTHERAPY STUDY
    Rodriguez-Torres, M.
    Glass, S.
    Hill, J.
    Freilich, B.
    Hassman, D.
    Di Bisceglie, A.
    Taylor, J. G.
    Kirby, B.
    Yang, J. C.
    Stamm, L. M.
    Brainard, D. M.
    Kim, S.
    Krefetz, D.
    Smith, W.
    Marbury, T.
    Lawitz, E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S682 - S682
  • [5] Transporter Roles in the Pharmacokinetics and Tissue Distribution of Voxilaprevir, a Pan-genotypic HCV NS3/4A Protease Inhibitor
    Wang, Yujin
    Yang, Chris
    Hao, Jia
    MacLennan, Kelly
    Wong, Belinda
    Mwangi, Judy
    Murray, Bernard
    Liang, Xiaomin
    Lai, Yurong
    Taylor, James G.
    FASEB JOURNAL, 2018, 32 (01):
  • [6] Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir
    Timm, Jennifer
    Kosovrasti, Klajdi
    Henes, Mina
    Leidner, Florian
    Hou, Shurong
    Ali, Akbar
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    ACS CHEMICAL BIOLOGY, 2020, 15 (02) : 342 - 352
  • [7] Characterization of HCV Resistance from a 3-Day Monotherapy Study of GS-9857, a Novel Pangenotypic NS3/4A Protease Inhibitor
    Lawitz, Eric
    Dvory-Sobol, Hadas
    Yang, Jenny C.
    Stamm, Luisa M.
    Taylor, James
    Brainard, Diana M.
    Miller, Michael D.
    Mo, Hongmei
    Rodriguez-Torres, Maribel
    HEPATOLOGY, 2015, 62 : 566A - 567A
  • [8] NOVEL, POTENT, PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITORS WITH A HIGH BARRIER TO RESISTANCE
    Buckman, B. O.
    Kossen, K.
    Nicholas, J. B.
    Serebryany, V.
    Ruhrmund, D.
    Rajagopalan, R.
    Misialek, S.
    Hooi, L.
    Aleskovski, N.
    Pan, L.
    Huang, L.
    Schaefer, C. J.
    Rajyaguru, S.
    Le Pogam, S.
    Najera, I.
    Klumpp, K.
    Seiwert, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S472 - S472
  • [9] Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease Inhibitors
    Shah, Unmesh
    Jayne, Charles
    Chackalamannil, Samuel
    Velazquez, Francisco
    Guo, Zhuyan
    Buevich, Alexei
    Howe, John A.
    Chase, Robert
    Soriano, Aileen
    Agrawal, Sony
    Rudd, Michael T.
    McCauley, John A.
    Liverton, Nigel J.
    Romano, Joseph
    Bush, Kimberly
    Coleman, Paul J.
    Grise-Bard, Christiane
    Brochu, Marie-Christine
    Charron, Sylvie
    Aulakh, Virender
    Bachand, Benoit
    Beaulieu, Patrick
    Zaghdane, Helmi
    Bhat, Sathesh
    Han, Yongxin
    Vacca, Joseph P.
    Davies, Ian W.
    Weber, Ann E.
    Venkatraman, Srikanth
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (03): : 264 - 269
  • [10] Novel quinoline-based P2-P4 macrocyclic derivatives as pan-genotypic HCV NS3/4a protease inhibitors
    Shah, Unmesh
    Jayne, Charles
    Chackalamannil, Samuel
    Guo, Zhuyan
    Howe, John
    Chase, Robert
    Soriano, Aileen
    Rudd, Michael T.
    McCauley, John A.
    Liverton, Nigel J.
    Romano, Joseph J.
    Bush, Kimberly J.
    Coleman, Paul J.
    Grise-Bard, Christiane
    Brochu, Marie-Christine
    Charron, Sylvie
    Aulakh, Virender
    Bachand, Benoit
    Beaulieu, Patrick
    Zaghdane, Helmi
    Bhat, Sathesh
    Han, Yongxin
    Vacca, Joseph P.
    Davies, Ian
    Venkatraman, Srikanth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247